Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoRecormon in anemic cancer patients
NCT02767765Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2003
- Primary completion
- Oct 2006
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin beta in anemia, sponsored by Roche. Started Jun 2003; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02767765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767765.